Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Aziridines
  • Benzoquinones
  • Meningeal Neoplasms

abstract

  • Intrathecal AZQ is safe, well tolerated, and highly active against refractory meningeal malignancies.

publication date

  • January 1992

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 1727916

Additional Document Info

start page

  • 143

end page

  • 8

volume

  • 10

number

  • 1